Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-04

Clinical Trial Update: Effect of Linagliptin on TRL Metabolism [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 clinical trial evaluating linagliptin's effect on triglyceride-rich lipoprotein metabolism in type 2 diabetes mell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linagliptin (linagliptin)

Snippet

Sponsor: Ministry of Public Health, Argentina | Conditions: Type 2 Diabetes | Phase 4 | Status: UNKNOWN